Macrophages require colony-stimulating factor 1 (CSF-1) to attain an M2-like immunosuppressive phenotype, and CSF-1 receptor inhibition represents a promising strategy to attenuate M2-like macrophages in GBM [34,35]. The gene discussed is CSF1R; the disease is glioblastoma.